Serum Levels of Selected Th17 and Th22 Cytokines in Psoriatic Patients

Abstract

Results of the conducted studies suggest that Th22 response may contribute to the skin and systemic inflammatory disease in psoriasis. It seems that early identification of soluble biomarkers and initiation of well-matched treatment may prevent exacerbation and progression of psoriasis.